Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Unknown 4Suspended 1Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 6

Conditions

Stomach Neoplasms 30Carcinoma, Hepatocellular 22Small Cell Lung Carcinoma 15Colorectal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Sarcoma 13Ovarian Neoplasms 12Breast Neoplasms 12Triple Negative Breast Neoplasms 9Nasopharyngeal Carcinoma 9Esophageal Squamous Cell Carcinoma 9Cholangiocarcinoma 9Biliary Tract Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Osteosarcoma 6Lung Neoplasms 6Pancreatic Neoplasms 5Head and Neck Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Thyroid Neoplasms 4Neoplasms 4Melanoma 4Solid Tumor 3Recurrence 3Neoplasm Metastasis 3Liver Neoplasms 3Glioma 3Carcinoma, Adenoid Cystic 3Advanced Gastric Cancer 3

Interventions

Ifosfamide 15Methotrexate 12Doxorubicin 12Filgrastim 10Cisplatin 10Cyclophosphamide 9Etoposide 8Gemcitabine 7cabozantinib 6apatinib 6Magnetic Resonance Spectroscopy 6Leucovorin 6X-Rays 5Specimen Handling 5Sirolimus 5Phantoms, Imaging 5Nivolumab 5Neoadjuvant Therapy 5camrelizumab 4Vincristine 4Topotecan 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Docetaxel 4Biopsy 4regorafenib 3palbociclib 3olaparib 3mifamurtide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Osteosarcoma × apatinib × Clear all
NCT04824352 2024-05-14

AIEO

Peking University People's Hospital

Phase 2 Suspended
44 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT06125171 2023-11-09

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
46 enrolled
Sarcoma

Osteosarcoma

NCT03742193 2023-11-01

PROACH

Ruijin Hospital

Phase 2 Unknown
43 enrolled
Sarcoma

Osteosarcoma

NCT03359018 2020-05-19

APFAO

Peking University People's Hospital

Phase 2 Completed
43 enrolled
Sarcoma

Osteosarcoma

NCT04351308 2020-05-19

MAPAC

Peking University People's Hospital

Phase 2 Unknown
60 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT03163381 2017-05-23

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

Henan Cancer Hospital

Phase 2 Unknown
40 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡